Amniotic Fluid Eye Drops(University of Utah)(Amniotic Fluid Eye Drops(University of Utah)) - 在研适应症：慢性移植物抗宿主病_专利_临床

概要

基本信息

药物类型

生物药

别名-

靶点-

作用机制-

治疗领域

免疫系统疾病其他疾病

在研适应症

慢性移植物抗宿主病

非在研适应症-

原研机构

University of Utah

在研机构

University of Utah

非在研机构-

最高研发阶段临床1/2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Amniotic Fluid Eye Drops(University of Utah) 相关的临床试验

NCT03298815

/ Completed临床1/2期IIT

A Randomized, Double-Blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)

A Randomized, Double-blinded, Placebo-Controlled Study for the Treatment of Ocular Chronic Graft Verses Host Disease with Processed Amniotic Fluid (pAF) Drops.

开始日期2019-12-20

申办/合作机构

University of Utah

100 项与 Amniotic Fluid Eye Drops(University of Utah) 相关的临床结果

登录后查看更多信息

100 项与 Amniotic Fluid Eye Drops(University of Utah) 相关的转化医学

登录后查看更多信息

100 项与 Amniotic Fluid Eye Drops(University of Utah) 相关的专利（医药）

登录后查看更多信息

1

项与 Amniotic Fluid Eye Drops(University of Utah) 相关的文献（医药）

1989-01-01·Ophthalmologica4区 · 医学

Therapy of Corneal Erosions and ‘Dry Eye’ with Solcoseryl® and Vitasic® Eye Drops

4区 · 医学

Article

作者: Rohde-Germann, H ; Straub, W ; Krannig, H M

A comparative study of Solcoseryl eye drops versus Vitasic eye drops has been carried out under controlled conditions (randomized and double-blind) on a total of 94 patients. 52 had corneal erosion, 30 had dry eye syndrome, 8 cases could not be evaluated. In addition, 2 eyes with photophthalmia were treated with Vitasic and 2 showing keratitis with Solcoseryl. There were no adverse reactions other than 2 instances of stinging with Solcoseryl and 1 case of severe irritation after Vitasic. The patients were examined on days 0, 1, 3 and 7. Results showed a consistent superiority of Solcoseryl eye drops in respect to speed of healing of corneal erosions and moistening of the cornea in the 'dry eye' syndrome which reached statistical significance in some parameters.

100 项与 Amniotic Fluid Eye Drops(University of Utah) 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
慢性移植物抗宿主病	临床2期	美国	University of Utah	2019-12-20

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


NCT03298815 (ASH2023)	临床2期	慢性移植物抗宿主病	15	Processed Amniotic Fluid (pAF) Drops (Processed Amniotic Fluid (pAF))	(艱鬱醖獵鹹觸網醖獵製) = 鏇鹽網構鏇獵廠衊網鹹衊蓋顧築壓遞夢窪餘範 (艱夢選艱齋遞糧壓壓糧 )	积极	2023-12-10
				Processed Amniotic Fluid (pAF) Drops (Saline treatment (placebo))	(艱鬱醖獵鹹觸網醖獵製) = 蓋餘築膚醖築膚醖顧醖衊蓋顧築壓遞夢窪餘範 (艱夢選艱齋遞糧壓壓糧 )